MSI Microbicides Monitor: 1-7 September 2009
Issue 4
Monday, 7 September 2009
--------------------------
The MSI Microbicides Monitor provides a weekly snapshot of major news pieces on microbicides research, advocacy and development from around the world, including news highlights from countries where clinical trials are taking place, and links to major microbicides-related events or other advocacy opportunities. This is issue 4 (1-7 September 2009):
--------------------------
The perils of success: What if the new HIV prevention methods work?
(Source: AIDSmap)
Within a couple of years' time, we may know if two crucial new HIV prevention approaches will work. If they do, what then? Who will pay for them, who will use them, and will their use have a positive or negative impact on the epidemic? A debate at the International AIDS Society (IAS) Conference in Cape Town in July, sponsored by the IAS and the AIDS Vaccine Advocacy Coalition (AVAC) looked at how to prepare for microbicides and pre-exposure prophylaxis (PrEP).
To remind you, a microbicide is a substance that can be incorporated into a lubricant, gel or barrier such as a diaphragm that will stop HIV transmission during sex. And PrEP is the concept of HIV-negative people taking anti-HIV drugs in advance of sex (or needle-sharing) to prevent HIV.
Over the next three years or so, crucial trials of these new prevention methods will announce their results. In 2010, we’ll have results from the biggest microbicide trial to date, the Microbicides Development Partnership trial of PRO2000 gel, followed by results from a US trial, too small to produce a definitive result, of PrEP in gay men.
By 2011 we'll know about tenofovir PrEP in Thai drug users, tenofovir/FTC PrEP in South American gay men, and tenofovir gel as a microbicide in South Africa. 2012 will offer PrEP results from men and women in Africa, and from a comparison trial of tenofovir as a microbicide and PrEP. And 2013 will see the end of HPTN052, a lengthy trial aiming for a definitive answer on whether treating everyone with HIV would stop onward transmission.
New prevention methods in HIV have had setbacks in the last few years, after the Merck HIV vaccine and a microbicide (cellulose sulphate) actually increased the risk of acquiring HIV. But following a promising result for the microbicide PRO2000 announced earlier this year, prevention advocates are daring to believe that positive results could be on their way. UNAIDS' chief epidemiologist, Catherine Hankins, commented: "I've got more of my chips down for PRO2000 than I did. We need to anticipate success and plan a very careful communication strategy." Read more
Molecular condom blocks HIV
(Source: Ethiopian Review)
Scientists have been working on microbicide gels for HIV for more than a decade. This type of prophylactic, which women could use without relying on their partners, is of particular interest in areas such as Sub-Saharan Africa, where HIV-infection rates are high and use of condoms is relatively low. But development has been slow–a number of products have failed clinical trials. Most of the topical microbicides being tested for HIV prevention contain antiviral drugs designed to block replication of the virus once it infects a cell. The new gel, which is being developed by Patrick Kiser and colleagues at the University of Utah, in Salt Lake City, acts at the first stage of infection–when the virus moves from semen to the surface of vaginal tissue. Read more
The battle in Uganda over female condoms
(Source: Ethiopian Review)
On the surface, it seems like a fine idea; reproductive-rights groups certainly think so. In July the Ugandan government announced that, using cash from the U.N. Population Fund, it would distribute 100,000 female condoms in a bid to stop a resurgence of HIV/AIDS. Advocates cheered the initiative, saying it would give women more control over their bodies. But in the weeks since, major funders of HIV/AIDS-prevention programs have shown far less enthusiasm, with many deciding not to back the plan. Instead of serving as a surefire weapon against the spread of HIV, Uganda's female-condoms initiative has become the latest example of the limitations faced by governments, advocacy groups and donors in the fight against the virus. Read more
IPM welcomes new COO and CHRO
(Source: International Partnership for Microbicides - IPM)
IPM announces two important additions to its strategic team: Mike Goldrich, former Executive Vice President and Chief Operating Officer at the International AIDS Vaccine Initiative (IAVI), has joined IPM as COO. Mr. Goldrich is responsible for providing strategic guidance to the IPM senior leadership team, and works collaboratively to manage operations across the organisation and within IPM’s global partner networks.
Kathleen T. Ross, former Executive Vice President and Chief Human Resources Officer at Arbitron, has joined IPM as CHRO. Ms. Ross is responsible for IPM's talent and organisational strategies, including staffing, retention and employee development; compensation, benefits and employee relations; and management, leadership and organisation development.
"Achieving IPM’s mission to develop and ensure access to safe and effective microbicides — and to support broader HIV prevention goals — hinges on the strength of our organisational capacity and leadership team," Dr. Zeda Rosenberg, Chief Executive Officer of IPM, said. "The expertise Mike and Kathleen bring will ensure that strategic growth within the organisation is skillfully carried out." Read more
-------------------------------
Upcoming events related to Microbicides
GCM - Microbicides Research Literacy Training (to be announced - Africa): December 2009
Microbicides International Conference, 2010 - Building bridges in HIV Prevention, Pittsburg, Pennsylvania, USA (22-25 May 2010)
-------------------------------
Produced and disseminated by Citizen News Service (CNS) for Microbicides Society of India (MSI)
Subscribe to:
Post Comments (Atom)
Thanks for posting the best information and the blog is very helpful.
ReplyDelete바카라사이트
Thanks for providing great informative blog, keep posting. 바카라사이트
ReplyDeleteOutstanding blog appreciating your endless efforts in coming up with an extraordinary content. 바둑이게임
ReplyDeleteI just got to this amazing site not long ago. I was actually captured with the piece of resources you have got here. 바카라사이트
ReplyDeletebetflix For entering to play our slot game website is very easy. Play slot games and easily break.
ReplyDeleteOh my goodness! Awesome article dude! Many thanks 바카라사이트
ReplyDeleteYour blog have nice information, I got good ideas from this amazing blog. 카지노사이트
ReplyDeleteI am happy I observed thiswebsite on Google. The site is fantastic. 온라인카지노
ReplyDeleteI enjoyed learning more about this topic. Nice post, thanks 바카라사이트닷컴
ReplyDeletehey anyone, I was just checkin out this blog and I really enjoy the basis of the article, and have nothing to do, so if anyone would like to to have an compelling conversation about it.
ReplyDelete메이저사이트
토토사이트
바카라
토토
Thanks for providing great informative blog, keep posting. I simply couldn't leave your site just my reading this blog. I am really impressed with the content and way of writing. Keep sharing more.
ReplyDeleteprotective order virginia
how to file for a protective order in virginia
The story of article is very well explained. Full of information. Amelia DUI Lawyer Virginia
ReplyDeleteabogado de accidentes
ReplyDeleteThe MSI Microbicides Monitor offers valuable information on microbicide research and development, but it could benefit from expanding on data and providing strategic insights. The report effectively provides an overview of current findings and trends, but more data and statistics are needed to support the findings. Additionally, recommendations on future directions and their potential impact could enhance the report's value for readers in the field.
As of my last knowledge update in January 2022, I don't have specific information about an MSI Microbicides Monitor 4LINES. It's possible that this is a product or a term that has emerged or been updated after my last training data in 2021.
ReplyDeleteMSI commonly refers to Microbicides Standardization Initiative, which is involved in the development and standardization of microbicides for the prevention of HIV and other sexually transmitted infections. estate and tax lawyer
ReplyDeleteThe MSI Microbicides Monitor for September 1-7, 2009, delivers timely updates and insights into the field of microbicide research and development. Through comprehensive reporting and analysis, it keeps stakeholders informed about the latest advancements and challenges in HIV prevention strategies. The Monitor's reliable coverage serves as a valuable resource for scientists, policymakers, and public health professionals striving to combat the HIV/AIDS epidemic. Its commitment to delivering accurate and up-to-date information contributes to the ongoing efforts to develop effective microbicide interventions.
truck accident attorney
MSI Microbicides Monitor: 1-7 September 2009
ReplyDeleteBlog Comment:
"This week's MSI Microbicides Monitor provided a comprehensive update on the latest developments in the field of microbicides. The insightful analysis of research findings and upcoming events highlighted the progress being made towards finding a solution to the HIV/AIDS pandemic. The detailed coverage of new studies and clinical trials gave me hope that we are moving closer to a viable prevention method. I appreciate the effort put into compiling this informative resource and look forward to future updates from MSI Microbicides Monitor."
ley de bancarrota cerca de mí
The MSI Microbicides Monitor for September 1-7, 2009, highlights the potential success of new HIV prevention methods, microbicides, and PrEP. Key trials, including the PRO2000 gel trial, will provide crucial results. However, previous setbacks include the Merck HIV vaccine and a microbicide that increased HIV risk. The University of Utah researchers have developed a new gel that blocks HIV at the initial stage of infection. Uganda's initiative to distribute 100,000 female condoms faces challenges despite advocacy support. IPM has welcomed Mike Goldrich as COO and Kathleen T. Ross as CHRO, focusing on talent and organizational strategies. The issue also covers the complexities of implementing prevention programs in different regions. abogado de testamentos y sucesiones
ReplyDeleteThe MSI Microbicides Monitor for September 1-7, 2009, delivers comprehensive ||New Jersey Extreme Risk Protection Order||Protección Orden Nueva Jersey updates on advancements and research in microbicide development.
ReplyDeleteThe MSI Microbicides Monitor for 1-7 September 2009 highlighted the latest developments in microbicides research and advocacy. One of the blog comments shared on the platform discussed the promising results of a recent clinical trial for a novel microbicide gel. The commenter expressed hope that this product could be a game-changer in the fight against HIV/AIDS, particularly for women in developing countries. They also emphasized the importance of continued investment in research and access to innovative prevention methods. Overall, the blog comment reflected a sense of optimism and support for advancing the field of microbicides to combat the global HIV epidemic.
ReplyDeletebrunswick va traffic lawyer
The Monitor highlighted key developments and news related to ongoing clinical trials, regulatory updates, and emerging research findings in the microbicide sector. It often featured insights into the effectiveness of various formulations, as well as discussions around safety and acceptability among potential users. abogados de child support en español
ReplyDelete